Journal of Women's Health
Volume 16, Issue 10, 2007, Pages 1447-1457
Cervical cancer screening among foreign-born women by birthplace and duration in the United States (Article)
Tsui J. ,
Saraiya M.* ,
Thompson T. ,
Dey A. ,
Richardson L.
-
a
Association of Schools of Public Health Fellow, Centers for Disease Control and Prevention, United States, UCLA, Center for Health Policy Research, Los Angeles, CA, United States
-
b
School of Public Health, Department of Health Services, Los Angeles, CA, United States, Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway MS K-55, Atlanta, GA 30341, United States
-
c
School of Public Health, Department of Health Services, Los Angeles, CA, United States
-
d
Centers for Disease Control and Prevention, Coordinating Center for Health Information and Services, National Center for Health Statistics, Hyattsville, MD, United States
-
e
School of Public Health, Department of Health Services, Los Angeles, CA, United States
Abstract
Objective: Mortality rates for cervical cancer have increased among foreign-born women in the United States in the last two decades. Previous research indicates that rates of Pap testing are lower among foreign-born women than in U.S.-born women. This study identifies screening rates among foreign-born women by birthplace and duration in the United States. Methods: We used data from 4 years (1998, 1999, 2000, 2003) of the National Health Interview Survey (NHIS) to estimate Pap testing rates by birthplace (Mexico, Central America, Caribbean, South America, Europe, Russia, Africa, Middle East, India, Asia, and Southeast Asia) and percent of lifetime spent in the United States for women aged ≥18 years (n = 70,775). Rates were age standardized to the 2000 U.S. population. Results: After adjusting for demographic characteristics and health indicators, we found that 18.6% (95% CI 16.7, 20.6) of recent immigrants (< 25% of lifetime in the United States) and 9.9% (95% CI 9.0, 10.8) of established immigrants (≥25% of lifetime in the United States)never received a Pap test in their lifetime compared with 5.8% (95% CI 5.5, 6.1) of U.S.-born women. Adjusted prevalence of never receiving a Pap test was highest among women from Asia, Southeast Asia, and India (19.6%), South America (12.7%), Mexico (11.2%), Caribbean (11.0%), Europe (9.9%), and Central America (9.2%). Conclusions: Significant differences exist in rates of screening for cervical cancer between foreign-born groups by birthplace and by duration in the United States. Nationally and locally funded screening programs may benefit from these findings in developing screening strategies for foreign-born women. © 2007 Mary Ann Liebert, Inc.
Author Keywords
[No Keywords available]
Index Keywords
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-36849063166&doi=10.1089%2fjwh.2006.0279&partnerID=40&md5=4093635a45e75fb2d1bf92c54b44a71e
DOI: 10.1089/jwh.2006.0279
ISSN: 15409996
Cited by: 69
Original Language: English